Cargando…
Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle
BACKGROUND: Subjective symptom complaints often do not match the expert’s ratings in focal dystonia. Nonetheless, perceived symptom intensities drive compliance and outcome of botulinum neurotoxin (BoNT) treatment. METHODS: Perception of symptom development across a BoNT cycle was obtained in 21 cer...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994697/ https://www.ncbi.nlm.nih.gov/pubmed/33403834 http://dx.doi.org/10.1002/brb3.2023 |
_version_ | 1783669808125968384 |
---|---|
author | Wöllner, Julia Weise, David Leplow, Bernd |
author_facet | Wöllner, Julia Weise, David Leplow, Bernd |
author_sort | Wöllner, Julia |
collection | PubMed |
description | BACKGROUND: Subjective symptom complaints often do not match the expert’s ratings in focal dystonia. Nonetheless, perceived symptom intensities drive compliance and outcome of botulinum neurotoxin (BoNT) treatment. METHODS: Perception of symptom development across a BoNT cycle was obtained in 21 cervical dystonia (CD) and 15 hemifacial spasm (HFS) patients at four time points during a BoNT cycle. Subjective assessments were recorded by means of a quality‐of‐life questionnaire and a patient diary containing items related to subjective severity of disease, mood, pain, social impairment, and quality of life. Medical investigation used the Tsui score and TWSTRS, and a HFS rating score, respectively. RESULTS: In both patient groups, subjective intensities were strongly associated with psychological variables. Only in CD did objective assessment moderately correlate with subjective ratings solely at the beginning and the end of the BoNT cycle. Overall, the beneficial effects of BoNT treatment were only loosely associated with subjective experiences in both groups. CONCLUSION: The emotional situation should be assessed regularly in patients undergoing BoNT therapy. |
format | Online Article Text |
id | pubmed-7994697 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79946972021-03-29 Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle Wöllner, Julia Weise, David Leplow, Bernd Brain Behav Original Research BACKGROUND: Subjective symptom complaints often do not match the expert’s ratings in focal dystonia. Nonetheless, perceived symptom intensities drive compliance and outcome of botulinum neurotoxin (BoNT) treatment. METHODS: Perception of symptom development across a BoNT cycle was obtained in 21 cervical dystonia (CD) and 15 hemifacial spasm (HFS) patients at four time points during a BoNT cycle. Subjective assessments were recorded by means of a quality‐of‐life questionnaire and a patient diary containing items related to subjective severity of disease, mood, pain, social impairment, and quality of life. Medical investigation used the Tsui score and TWSTRS, and a HFS rating score, respectively. RESULTS: In both patient groups, subjective intensities were strongly associated with psychological variables. Only in CD did objective assessment moderately correlate with subjective ratings solely at the beginning and the end of the BoNT cycle. Overall, the beneficial effects of BoNT treatment were only loosely associated with subjective experiences in both groups. CONCLUSION: The emotional situation should be assessed regularly in patients undergoing BoNT therapy. John Wiley and Sons Inc. 2021-01-05 /pmc/articles/PMC7994697/ /pubmed/33403834 http://dx.doi.org/10.1002/brb3.2023 Text en © 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Wöllner, Julia Weise, David Leplow, Bernd Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle |
title | Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle |
title_full | Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle |
title_fullStr | Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle |
title_full_unstemmed | Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle |
title_short | Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle |
title_sort | subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994697/ https://www.ncbi.nlm.nih.gov/pubmed/33403834 http://dx.doi.org/10.1002/brb3.2023 |
work_keys_str_mv | AT wollnerjulia subjectiveversusobjectivesymptomintensitiesratingsincervicaldystoniaandhemifacialspasmacrossabotulinumneurotoxincycle AT weisedavid subjectiveversusobjectivesymptomintensitiesratingsincervicaldystoniaandhemifacialspasmacrossabotulinumneurotoxincycle AT leplowbernd subjectiveversusobjectivesymptomintensitiesratingsincervicaldystoniaandhemifacialspasmacrossabotulinumneurotoxincycle |